Article
Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells.
Human gene therapy - 1 Nov 2018
Zhou Miaojin, Hu Zhiqing, Qiu Liyan, Zhou Tao, Feng Mai, Hu Qian, Zeng Baitao, Li Zhuo, Sun Qianru, Wu Yong, Liu Xionghao, Wu Lingqian, Liang Desheng
Abstract excerpt
Spinal muscular atrophy (SMA) is a kind of neuromuscular disease characterized by progressive motor neuron loss in the spinal cord. It is caused by mutations in the survival motor neuron 1 (SMN1) gene. SMN1 has a paralogous gene, survival motor neuron 2 (SMN2), in humans that is present in almost all SMA patients. The generation and genetic correction of SMA patient-specific induced pluripotent stem cells (iPSCs)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
